Position paper - Open consultation response on the revision of the general pharmaceutical legislation

The European Commission’s revision of the EU general pharmaceutical legislation Pharmaceutical Strategy aims at supporting the evaluation of the existing general pharmaceutical legislation on medicines for human use, with the purpose of ensuring a future-proof and crisis-resistant medicines regulatory system. The revision of the pharmaceutical legislation should enable an environment for the biopharmaceutical sector to flourish and help the EU remain competitive on the global stage. As making healthcare systems more resilient and sustainable continues to be a priority, it is critical to maintain frameworks that reward innovation and attract investment.